[1]
K. . Zheng, T. . Qu, L. Han, and Y. . Sun, “The role of serum BAFF, CFB, MCP-1 and anti-PLA2R antibodies in the efficacy evaluation of patients with membranous nephropathy: Serum BAFF, CFB, MCP-1 and anti-PLA2R antibodies in membranous nephropathy”, J Med Biochem, vol. 45, no. 6, pp. 1420–1429, Dec. 2025, doi: 10.5937/jomb0-61102.